[ad_1]
Gut microbiota and metabolic-associated steatosis liver disease: Unveiling mechanisms and opportunities for therapeutic intervention Baishideng Publishing Group
[ad_2]
Related Posts
Neoadjuvant Chemo/Nivolumab Yields Deep Responses in Borderline-Resectable PDAC Subset
- admin
- February 19, 2026
- 0
[ad_1] Neoadjuvant modified FOLFIRINOX (mFOLFIRINOX)—oxaliplatin, leucovorin, irinotecan, and 5-fluorourcail—plus nivolumab (Opdivo) was safe and efficacious in patients with borderline-resectable pancreatic ductal adenocarcinoma (PDAC), according to […]
Early Release – Oral Transmission of Classical Bovine Spongiform Encephalopathy in ARR/ARR Sheep – Volume 31, Number 12—December 2025 – Emerging Infectious Diseases journal
- admin
- December 24, 2025
- 0
[ad_1] Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article […]
Prostatic Abscess Due to Dual Infection With Mycobacterium tuberculosis and Stenotrophomonas maltophilia – Cureus
- admin
- December 23, 2025
- 0
[ad_1] Prostatic Abscess Due to Dual Infection With Mycobacterium tuberculosis and Stenotrophomonas maltophilia Cureus [ad_2]